196 related articles for article (PubMed ID: 31513075)
1. Some Aspects of CD8+ T-Cell Exhaustion Are Associated With Altered T-Cell Mitochondrial Features and ROS Content in HIV Infection.
Deguit CDT; Hough M; Hoh R; Krone M; Pilcher CD; Martin JN; Deeks SG; McCune JM; Hunt PW; Rutishauser RL
J Acquir Immune Defic Syndr; 2019 Oct; 82(2):211-219. PubMed ID: 31513075
[TBL] [Abstract][Full Text] [Related]
2. Antiretroviral therapy initiation during primary HIV infection enhances both CD127 expression and the proliferative capacity of HIV-specific CD8+ T cells.
Lécuroux C; Girault I; Boutboul F; Urrutia A; Goujard C; Meyer L; Lambotte O; Chaix ML; Martinez V; Autran B; Sinet M; Venet A; ; ;
AIDS; 2009 Aug; 23(13):1649-58. PubMed ID: 19617814
[TBL] [Abstract][Full Text] [Related]
3. Inverted CD8 T-Cell Exhaustion and Co-Stimulation Marker Balance Differentiate Aviremic HIV-2-Infected From Seronegative Individuals.
Scharf L; Pedersen CB; Johansson E; Lindman J; Olsen LR; Buggert M; Wilhelmson S; Månsson F; Esbjörnsson J; Biague A; Medstrand P; Norrgren H; Karlsson AC; Jansson M;
Front Immunol; 2021; 12():744530. PubMed ID: 34712231
[TBL] [Abstract][Full Text] [Related]
4. Early skewed distribution of total and HIV-specific CD8+ T-cell memory phenotypes during primary HIV infection is related to reduced antiviral activity and faster disease progression.
Ghiglione Y; Falivene J; Ruiz MJ; Laufer N; Socías ME; Cahn P; Giavedoni L; Sued O; Gherardi MM; Salomón H; Turk G
PLoS One; 2014; 9(8):e104235. PubMed ID: 25093660
[TBL] [Abstract][Full Text] [Related]
5. HIV-induced T-cell activation/exhaustion in rectal mucosa is controlled only partially by antiretroviral treatment.
Rueda CM; Velilla PA; Chougnet CA; Montoya CJ; Rugeles MT
PLoS One; 2012; 7(1):e30307. PubMed ID: 22276176
[TBL] [Abstract][Full Text] [Related]
6. Immune Activation and HIV-Specific CD8(+) T Cells in Cerebrospinal Fluid of HIV Controllers and Noncontrollers.
Ganesh A; Lemongello D; Lee E; Peterson J; McLaughlin BE; Ferre AL; Gillespie GM; Fuchs D; Deeks SG; Hunt PW; Price RW; Spudich SS; Shacklett BL
AIDS Res Hum Retroviruses; 2016 Aug; 32(8):791-800. PubMed ID: 27019338
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-155 is a biomarker of T-cell activation and immune dysfunction in HIV-1-infected patients.
Jin C; Cheng L; Höxtermann S; Xie T; Lu X; Wu H; Skaletz-Rorowski A; Brockmeyer NH; Wu N
HIV Med; 2017 May; 18(5):354-362. PubMed ID: 27981723
[TBL] [Abstract][Full Text] [Related]
8. Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8+ T-cell exhaustion in HIV infection.
Yamamoto T; Price DA; Casazza JP; Ferrari G; Nason M; Chattopadhyay PK; Roederer M; Gostick E; Katsikis PD; Douek DC; Haubrich R; Petrovas C; Koup RA
Blood; 2011 May; 117(18):4805-15. PubMed ID: 21398582
[TBL] [Abstract][Full Text] [Related]
9. Exhaustion of Activated CD8 T Cells Predicts Disease Progression in Primary HIV-1 Infection.
Hoffmann M; Pantazis N; Martin GE; Hickling S; Hurst J; Meyerowitz J; Willberg CB; Robinson N; Brown H; Fisher M; Kinloch S; Babiker A; Weber J; Nwokolo N; Fox J; Fidler S; Phillips R; Frater J;
PLoS Pathog; 2016 Jul; 12(7):e1005661. PubMed ID: 27415828
[TBL] [Abstract][Full Text] [Related]
10. Prolonged Antiretroviral Therapy in Adolescents With Vertical HIV Infection Leads to Different Cytokine Profiles Depending on Viremia Persistence.
Munhoz LGC; Garcia Spina F; Machado DM; Gouvea A; Succi RCM; Diaz RS; De Moraes-Pinto MI
Pediatr Infect Dis J; 2019 Nov; 38(11):1115-1120. PubMed ID: 31626046
[TBL] [Abstract][Full Text] [Related]
11. Partial recovery of senescence and differentiation disturbances in CD8
Eberhard JM; Ahmad F; Hong HS; Bhatnagar N; Keudel P; Schulze Zur Wiesch J; Schmidt RE; Meyer-Olson D
Clin Exp Immunol; 2016 Nov; 186(2):227-238. PubMed ID: 27377704
[TBL] [Abstract][Full Text] [Related]
12. GB virus C infection is associated with altered lymphocyte subset distribution and reduced T cell activation and proliferation in HIV-infected individuals.
Stapleton JT; Chaloner K; Martenson JA; Zhang J; Klinzman D; Xiang J; Sauter W; Desai SN; Landay A
PLoS One; 2012; 7(11):e50563. PubMed ID: 23209780
[TBL] [Abstract][Full Text] [Related]
13. CD4+CD25+CD127- assessment as a surrogate phenotype for FOXP3+ regulatory T cells in HIV-1 infected viremic and aviremic subjects.
Saison J; Demaret J; Venet F; Chidiac C; Malcus C; Poitevin-Later F; Tardy JC; Ferry T; Monneret G
Cytometry B Clin Cytom; 2013; 84(1):50-4. PubMed ID: 23019018
[TBL] [Abstract][Full Text] [Related]
14. Assessment of metabolic and mitochondrial dynamics in CD4+ and CD8+ T cells in virologically suppressed HIV-positive individuals on combination antiretroviral therapy.
Masson JJR; Murphy AJ; Lee MKS; Ostrowski M; Crowe SM; Palmer CS
PLoS One; 2017; 12(8):e0183931. PubMed ID: 28854263
[TBL] [Abstract][Full Text] [Related]
15. CD127 expression and regulation are altered in the memory CD8 T cells of HIV-infected patients--reversal by highly active anti-retroviral therapy (HAART).
Colle JH; Moreau JL; Fontanet A; Lambotte O; Joussemet M; Delfraissy JF; Thèze J
Clin Exp Immunol; 2006 Mar; 143(3):398-403. PubMed ID: 16487237
[TBL] [Abstract][Full Text] [Related]
16. Delayed Expression of PD-1 and TIGIT on HIV-Specific CD8 T Cells in Untreated HLA-B*57:01 Individuals Followed from Early Infection.
Scharf L; Tauriainen J; Buggert M; Hartogensis W; Nolan DJ; Deeks SG; Salemi M; Hecht FM; Karlsson AC
J Virol; 2020 Jul; 94(14):. PubMed ID: 32350076
[TBL] [Abstract][Full Text] [Related]
17. Characterization of CD31 expression in CD4+ and CD8+T cell subpopulations in chronic untreated HIV infection.
Briceño O; Peralta-Prado A; Garrido-Rodríguez D; Romero-Mora K; Chávez-Torres M; de la Barrera CA; Reyes-Terán G; Ávila-Ríos S
Immunol Lett; 2021 Jul; 235():22-31. PubMed ID: 33852965
[TBL] [Abstract][Full Text] [Related]
18. Immunosenescence of the CD8(+) T cell compartment is associated with HIV-infection, but only weakly reflects age-related processes of adipose tissue, metabolism, and muscle in antiretroviral therapy-treated HIV-infected patients and controls.
Tavenier J; Langkilde A; Haupt TH; Henriksen JH; Jensen FK; Petersen J; Andersen O
BMC Immunol; 2015 Nov; 16():72. PubMed ID: 26611787
[TBL] [Abstract][Full Text] [Related]
19. CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.
Koofhethile CK; Ndhlovu ZM; Thobakgale-Tshabalala C; Prado JG; Ismail N; Mncube Z; Mkhize L; van der Stok M; Yende N; Walker BD; Goulder PJR; Ndung'u T
J Virol; 2016 Aug; 90(15):6818-6831. PubMed ID: 27194762
[TBL] [Abstract][Full Text] [Related]
20. Augmentation of HIV-specific T cell function by immediate treatment of hyperacute HIV-1 infection.
Ndhlovu ZM; Kazer SW; Nkosi T; Ogunshola F; Muema DM; Anmole G; Swann SA; Moodley A; Dong K; Reddy T; Brockman MA; Shalek AK; Ndung'u T; Walker BD
Sci Transl Med; 2019 May; 11(493):. PubMed ID: 31118290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
